These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12670779)

  • 1. Bronchodilator response to formoterol Turbuhaler in patients with COPD under regular treatment with formoterol Turbuhaler.
    Cazzola M; Matera MG; D'Amato M; Califano C; Sanduzzi A; Vatrella A; D'Amato G
    Pulm Pharmacol Ther; 2003; 16(2):105-9. PubMed ID: 12670779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD.
    Derom E; Strandgården K; Schelfhout V; Borgström L; Pauwels R
    Respir Med; 2007 Sep; 101(9):1931-41. PubMed ID: 17544264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease.
    Cazzola M; D'Amato M; Califano C; Di Perna F; Calderaro E; Matera MG; D'Amato G
    Clin Ther; 2002 Apr; 24(4):595-604. PubMed ID: 12017404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: phase III multinational study results.
    Fukuchi Y; Samoro R; Fassakhov R; Taniguchi H; Ekelund J; Carlsson LG; Ichinose M
    Respirology; 2013 Jul; 18(5):866-73. PubMed ID: 23551359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically equivalent bronchodilatation achieved with formoterol delivered via Easyhaler and Aerolizer.
    Dubakiene R; Nargela R; Sakalauskas R; Vahteristo M; Silvasti M; Lähelmä S
    Respiration; 2006; 73(4):441-8. PubMed ID: 16432294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD.
    Cazzola M; Noschese P; De Michele F; D'Amato G; Matera MG
    Respir Med; 2006 Feb; 100(2):212-7. PubMed ID: 15936184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPD.
    Cazzola M; Centanni S; Regorda C; di Marco F; di Perna F; Carlucci P; Boveri B; Santus P
    Pulm Pharmacol Ther; 2001; 14(1):41-5. PubMed ID: 11162418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formoterol Turbuhaler 4.5 microg (delivered dose) has a rapid onset and 12-h duration of bronchodilation.
    Selroos O; Ekström T
    Pulm Pharmacol Ther; 2002; 15(2):175-83. PubMed ID: 12090792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24-hour bronchodilator efficacy of single doses of indacaterol in subjects with COPD: comparison with placebo and formoterol.
    Bauwens O; Ninane V; Van de Maele B; Firth R; Dong F; Owen R; Higgins M
    Curr Med Res Opin; 2009 Feb; 25(2):463-70. PubMed ID: 19192991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
    Partridge MR; Schuermann W; Beckman O; Persson T; Polanowski T
    Ther Adv Respir Dis; 2009 Aug; 3(4):1-11. PubMed ID: 19734176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once versus twice daily formoterol via Novolizer for patients with moderate to severe COPD--a double-blind, randomised, controlled trial.
    Welte T; Metzenauer P; Hartmann U
    Pulm Pharmacol Ther; 2008; 21(1):4-13. PubMed ID: 17101285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formoterol Turbuhaler for as-needed therapy in patients with mild acute exacerbations of COPD.
    Cazzola M; Di Perna F; D'Amato M; Califano C; Matera MG; D'Amato G
    Respir Med; 2001 Nov; 95(11):917-21. PubMed ID: 11716207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A; Szalai Z; Pullerits T; Radeczky E
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose comparison of formoterol (Oxis) Turbuhaler 6 microg and formoterol Aerolizer 12 microg in moderate to severe asthma: a randomised, crossover study.
    Schlimmer P
    Pulm Pharmacol Ther; 2002; 15(4):369-74. PubMed ID: 12220942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchodilator effects of indacaterol and formoterol in patients with COPD.
    Beier J; Beeh KM; Brookman L; Peachey G; Hmissi A; Pascoe S
    Pulm Pharmacol Ther; 2009 Dec; 22(6):492-6. PubMed ID: 19465142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of high-dose formoterol (via Aerolizer) and salbutamol in patients with chronic obstructive pulmonary disease.
    Rosenkranz B; Rouzier R; Kruse M; Dobson C; Ayre G; Horowitz A; Fitoussi S
    Respir Med; 2006 Apr; 100(4):666-72. PubMed ID: 16303295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPD.
    Cazzola M; Santus P; Di Marco F; Carlucci P; Mondoni M; Matera MG; Centanni S
    Pulm Pharmacol Ther; 2004; 17(3):121-5. PubMed ID: 15123220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.